发明名称 composição, métodos para reduzir um ou mais efeitos colaterais da terapia de glicocorticóide, e para tratar ou previnir um padrão de secreção de glicocorticóide endógeno diminuído ou interrompido em um paciente.
摘要 The present invention relates to improved glucocorticoid therapy and to treatment or prevention of a number of disorders that are due to a diminished or disrupted endogenous glucocorticoid secretory pattern. The invention is based on the findings that producing a specific serum Cortisol time profile that mimics the circadian rhythm of Cortisol of a healthy subject in a subject suffering from a diminished or disrupted glucocorticoid secretory pattern gives benefits with respect to reduction of side-effects.
申请公布号 BRPI1011624(A2) 申请公布日期 2016.03.22
申请号 BR2010PI11624 申请日期 2010.04.07
申请人 DUOCORT PHARMA AB 发明人 GUDMUNDUR JOHANNSSON;HANS LENNERNÄS;JÖRGEN JOHNSSON;STANKO SKRTIC;THOMAS HEDNER
分类号 A61K31/573;A61P5/44 主分类号 A61K31/573
代理机构 代理人
主权项
地址